Publications by authors named "Luca Salvatore Menga"

Background: Positive end-expiratory pressure (PEEP) benefits in acute respiratory distress syndrome are driven by lung dynamic strain reduction. This depends on the variable extent of alveolar recruitment. The recruitment-to-inflation ratio estimates recruitability across a 10-cm H2O PEEP range through a simplified maneuver.

View Article and Find Full Text PDF

Acute respiratory distress syndrome (ARDS) is a leading cause of disability and mortality worldwide, and while no specific etiologic interventions have been shown to improve outcomes, noninvasive and invasive respiratory support strategies are life-saving interventions that allow time for lung recovery. However, the inappropriate management of these strategies, which neglects the unique features of respiratory, lung, and chest wall mechanics may result in disease progression, such as patient self-inflicted lung injury during spontaneous breathing or by ventilator-induced lung injury during invasive mechanical ventilation. ARDS characteristics are highly heterogeneous; therefore, a physiology-based approach is strongly advocated to titrate the delivery and management of respiratory support strategies to match patient characteristics and needs to limit ARDS progression.

View Article and Find Full Text PDF

Optimal initial non-invasive management of acute hypoxemic respiratory failure (AHRF), of both coronavirus disease 2019 (COVID-19) and non-COVID-19 etiologies, has been the subject of significant discussion. Avoidance of endotracheal intubation reduces related complications, but maintenance of spontaneous breathing with intense respiratory effort may increase risks of patients' self-inflicted lung injury, leading to delayed intubation and worse clinical outcomes. High-flow nasal oxygen is currently recommended as the optimal strategy for AHRF management for its simplicity and beneficial physiological effects.

View Article and Find Full Text PDF

Background: There is growing interest towards the use of helmet noninvasive ventilation (NIV) for the management of acute hypoxemic respiratory failure. Gas conditioning through heat and moisture exchangers (HME) or heated humidifiers (HHs) is needed during facemask NIV to provide a minimum level of humidity in the inspired gas (15 mg HO/L). The optimal gas conditioning strategy during helmet NIV remains to be established.

View Article and Find Full Text PDF
Article Synopsis
  • The "Berlin definition" of ARDS currently excludes patients on high-flow nasal oxygen (HFNO), but there's ongoing debate about expanding the criteria to include them.
  • Researchers studied COVID-19 patients using HFNO and noninvasive ventilation (NIV) to compare ARDS severity and 28-day mortality before and after transitioning to invasive mechanical ventilation (IMV).
  • The study found that patients who remained on HFNO had significantly lower 28-day mortality rates compared to those who transitioned to IMV, suggesting that including HFNO patients in the ARDS definition could help identify those at earlier stages of the disease with better survival outcomes.
View Article and Find Full Text PDF

Background: A correlation between unsuccessful noninvasive ventilation (NIV) and poor outcome has been suggested in de-novo Acute Respiratory Failure (ARF) patients. Consequently, it is of paramount importance to identify accurate predictors of NIV outcome. The aim of our preliminary study is to evaluate the Diaphragmatic Thickening Fraction (DTF) and the respiratory rate/DTF ratio as predictors of NIV outcome in de-novo ARF patients.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the effectiveness of noninvasive oxygenation strategies (NIOS) in treating COVID-19 patients with hypoxemic respiratory failure in the ICU.
  • Out of 85 patients treated, 61% required endotracheal intubation, with specific clinical indicators (SAPS II score and lactate dehydrogenase levels) being significant predictors of NIOS failure.
  • When compared to patients with hypoxemic respiratory failure from other causes, those with COVID-19 had a significantly higher NIOS failure rate (59% vs 35%), indicating a need for careful monitoring and alternative treatment approaches for this population.
View Article and Find Full Text PDF

Purpose Of Review: We review the evidence on the use of noninvasive respiratory supports (noninvasive ventilation and high-flow nasal cannula oxygen therapy) in patients with acute respiratory failure because of severe community-acquired pneumonia.

Recent Findings: Noninvasive ventilation is strongly advised for the treatment of hypercapnic respiratory failure and recent evidence justifies its use in patients with hypoxemic respiratory failure when delivered by helmet. Indeed, such interface allows alveolar recruitment by providing high level of positive end-expiratory pressure, which improves hypoxemia.

View Article and Find Full Text PDF